Complejo Hospitalario Universitario de Santiago de Compostela


Hospital

Location:
Santiago de Compostela, Spain


Publications in cooperation with FAU scientists


Gladman, D.D., Kavanaugh, A., Gomez-Reino, J.J., Wollenhaupt, J., Cutolo, M., Schett, G.,... Mease, P.J. (2018). LONG-TERM (156-WEEK) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS WITH APREMILAST INPSORIATIC ARTHRITIS SUBJECTS: ANALYSIS OF A LARGE, POOLED PALACE 1-3 DATABASE.
Gladman, D.D., Kavanaugh, A., Gomez-Reino, J.J., Wollenhaupt, J., Cutolo, M., Schett, G.,... Mease, P.J. (2017). APREMILAST TREATMENT AND LONG-TERM (UP TO 156 WEEKS) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF A LARGE DATABASE OF THE PHASE III CLINICAL DEVELOPMENT PROGRAM. (pp. 942-942).
Achenbach, S., Paul, J.-F., Laurent, F., Becker, H.-C., Rengo, M., Caudron, J.,... Cademartiri, F. (2017). Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial. European Radiology, 27(2), 821-830. https://dx.doi.org/10.1007/s00330-016-4437-9
Mease, P.J., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Kavanaugh, A., Lespessailles, E.,... Wollenhaupt, J. (2017). Consistent Safety Profile with up to 4 Years of Apremilast Treatment: Analysis of Data from 1,493 Subjects with Psoriatic Arthritis in 3 Large, Phase III, Long-Term Studies.
Kavanaugh, A., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Lespessailles, E., Mease, P.J.,... Wollenhaupt, J. (2017). DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL. (pp. 936-937).
Achenbach, S., Paul, J.-F., Laurent, F., Becker, H.-C., Rengo, M., Caudron, J.,... Cademartiri, F. (2017). Erratum to: Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial. European Radiology, 27(2), 831-831. https://dx.doi.org/10.1007/s00330-016-4557-2
Barrdahl, M., Rudolph, A., Hopper, J.L., Southey, M.C., Broeks, A., Fasching, P.,... Chang-Claude, J. (2017). Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. International Journal of Cancer, 141(9), 1830-1840. https://dx.doi.org/10.1002/ijc.30859
Gladman, D.D., Kavanaugh, A., Adebajo, A.O., Gomez-Reino, J.J., Wollenhaupt, J., Cutolo, M.,... Mease, P.J. (2016). APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS. (pp. 33-34).
Gladman, D., Kavanaugh, A., Adebajo, A., Gomez-Reino, J., Wollenhaupt, J., Cutolo, M.,... Mease, P. (2016). Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials. (pp. 1169-1169).
Gladman, D.D., Kavanaugh, A., Gomez-Reino, J.J., Wollenhaupt, J., Cutolo, M., Schett, G.,... Mease, P.J. (2016). Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials.
Mease, P.J., Gladman, D.D., Gomez-Reino, J.J., Hall, S., Kavanaugh, A., Lespessailles, E.,... Wollenhaupt, J. (2016). Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials.
Kavanaugh, A., Mease, P.J., Gomez-Reino, J.J., Adebajo, A.O., Wollenhaupt, J., Gladman, D.D.,... Schett, G. (2014). Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Annals of the Rheumatic Diseases, 73(6), 1020-6. https://dx.doi.org/10.1136/annrheumdis-2013-205056

Last updated on 2016-28-11 at 12:48